PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
LABD vs. FNGD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


LABDFNGD
YTD Return-40.60%-72.26%
1Y Return-72.00%-76.97%
3Y Return (Ann)-33.23%-64.08%
5Y Return (Ann)-55.99%-77.90%
Sharpe Ratio-0.96-1.11
Sortino Ratio-1.84-2.44
Omega Ratio0.800.73
Calmar Ratio-0.77-0.79
Martin Ratio-1.23-1.43
Ulcer Index62.23%54.95%
Daily Std Dev79.50%71.00%
Max Drawdown-99.97%-99.98%
Current Drawdown-99.97%-99.98%

Correlation

-0.50.00.51.00.6

The correlation between LABD and FNGD is 0.55, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

LABD vs. FNGD - Performance Comparison

In the year-to-date period, LABD achieves a -40.60% return, which is significantly higher than FNGD's -72.26% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-30.00%-20.00%-10.00%0.00%10.00%20.00%30.00%JuneJulyAugustSeptemberOctoberNovember
-24.81%
-33.33%
LABD
FNGD

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


LABD vs. FNGD - Expense Ratio Comparison

LABD has a 1.06% expense ratio, which is higher than FNGD's 0.95% expense ratio.


LABD
Direxion Daily S&P Biotech Bear 3x Shares
Expense ratio chart for LABD: current value at 1.06% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.06%
Expense ratio chart for FNGD: current value at 0.95% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.95%

Risk-Adjusted Performance

LABD vs. FNGD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and MicroSectors FANG+™ Index -3X Inverse Leveraged ETN (FNGD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LABD
Sharpe ratio
The chart of Sharpe ratio for LABD, currently valued at -0.96, compared to the broader market-2.000.002.004.006.00-0.96
Sortino ratio
The chart of Sortino ratio for LABD, currently valued at -1.84, compared to the broader market-2.000.002.004.006.008.0010.0012.00-1.84
Omega ratio
The chart of Omega ratio for LABD, currently valued at 0.80, compared to the broader market1.001.502.002.503.000.80
Calmar ratio
The chart of Calmar ratio for LABD, currently valued at -0.77, compared to the broader market0.005.0010.0015.00-0.77
Martin ratio
The chart of Martin ratio for LABD, currently valued at -1.23, compared to the broader market0.0020.0040.0060.0080.00100.00120.00-1.23
FNGD
Sharpe ratio
The chart of Sharpe ratio for FNGD, currently valued at -1.11, compared to the broader market-2.000.002.004.006.00-1.11
Sortino ratio
The chart of Sortino ratio for FNGD, currently valued at -2.44, compared to the broader market-2.000.002.004.006.008.0010.0012.00-2.44
Omega ratio
The chart of Omega ratio for FNGD, currently valued at 0.73, compared to the broader market1.001.502.002.503.000.73
Calmar ratio
The chart of Calmar ratio for FNGD, currently valued at -0.79, compared to the broader market0.005.0010.0015.00-0.79
Martin ratio
The chart of Martin ratio for FNGD, currently valued at -1.43, compared to the broader market0.0020.0040.0060.0080.00100.00120.00-1.43

LABD vs. FNGD - Sharpe Ratio Comparison

The current LABD Sharpe Ratio is -0.96, which is comparable to the FNGD Sharpe Ratio of -1.11. The chart below compares the historical Sharpe Ratios of LABD and FNGD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.20-1.00-0.80-0.60-0.40JuneJulyAugustSeptemberOctoberNovember
-0.96
-1.11
LABD
FNGD

Dividends

LABD vs. FNGD - Dividend Comparison

LABD's dividend yield for the trailing twelve months is around 5.34%, while FNGD has not paid dividends to shareholders.


TTM202320222021202020192018
LABD
Direxion Daily S&P Biotech Bear 3x Shares
5.34%6.14%0.53%0.00%3.96%1.75%0.80%
FNGD
MicroSectors FANG+™ Index -3X Inverse Leveraged ETN
0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

LABD vs. FNGD - Drawdown Comparison

The maximum LABD drawdown since its inception was -99.97%, roughly equal to the maximum FNGD drawdown of -99.98%. Use the drawdown chart below to compare losses from any high point for LABD and FNGD. For additional features, visit the drawdowns tool.


-100.00%-99.80%-99.60%-99.40%-99.20%JuneJulyAugustSeptemberOctoberNovember
-99.49%
-99.98%
LABD
FNGD

Volatility

LABD vs. FNGD - Volatility Comparison

Direxion Daily S&P Biotech Bear 3x Shares (LABD) and MicroSectors FANG+™ Index -3X Inverse Leveraged ETN (FNGD) have volatilities of 17.00% and 17.57%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


15.00%20.00%25.00%30.00%JuneJulyAugustSeptemberOctoberNovember
17.00%
17.57%
LABD
FNGD